Keyword: Joseph Jimenez

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...

Markets & Companies

Drugs Industry Battered by Currency and Competition

13.03.2015 - Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...

News

EC Approves Novartis-GSK Asset Swap With Strings

30.01.2015 - The European Commission has approved a plan by Novartis and GlaxoSmithKline to swap assets worth more than $20 billion. The proposed deal dates back to April 2014, when Switzerland...

Strategy & Management

International Drugmakers Meet Challenges

08.05.2014 - In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...

News

Novartis CEO Says U.S. Plant Gets FDA Clearance

09.11.2012 - Swiss drugmaker Novartis's plant in Colorado, has just passed an inspection by U.S. regulators, giving it hope that quality control problems in its North American plants are being...

News

Novartis Posts Higher Q2 Profit

19.07.2011 - Novartis reported second-quarter net income of $2.73 billion or $1.13 per share versus $2.44 billion or $1.06 per share in the year-ago quarter. Core net income for the quarter...